Health Condition 1: K063- Horizontal alveolar bone loss
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who are willing to replace the missing teeth with implants in single or multiple edentulous sites with Adequate bone height of 10mm and bone width of 6mm No systemic illness
Exclusion criteria
Exclusion criteria: Uncontrolled diabetics mellitus History of bone metabolic disorders History of smoking more than 10 cigarettes per day Inadequate bone volume Presence of untreated periapical kesions , cysts and tumours pregnancy and lactating mothers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The study is expected to demonstrate that the application of Bone Bioactive Liquid (BBL) at the implant site enhances osseointegration by improving implant stability and bone turnover activity compared to conventional implant placement.Timepoint: Baseline , 1 month and 3 months post implantation | — |
Secondary
| Measure | Time frame |
|---|---|
| Implant Stability Quotient (ISQ) values measured using Resonance Frequency Analysis (RFA)Timepoint: Baseline , 1 month & 3 months | — |
Countries
India
Contacts
Sri Ramachandra Institute of Higher Educatiin and Research